LITH.US US Lithium Corp

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Oct 6, 2026
0.0001 0.0002
Market cap
USD 940.00
P/E
-
P/B
0.14x
ROE
-1,429.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2019.

Is LITH.US undervalued?

Graham number

The Graham number of US Lithium Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

US Lithium Corp fundamental analysis

No fundamental analysis for US Lithium Corp yet.

US Lithium Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About US Lithium Corp

BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.

Full company profile